MedAdvisor, Zuellig Pharma in JV to market medication management solutions in Asia

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

AUSTRALIAN medication platform MedAdvisor and healthcare service provider Zuellig Pharma have formed a 50:50 Singapore-based joint venture (JV) ZP MedAdvisor (ZPM) to commercialise MedAdvisor’s platform across Asia. Read more at The Business Times.

AUSTRALIAN medication platform MedAdvisor and healthcare service provider Zuellig Pharma have formed a 50:50 Singapore-based joint venture ZP MedAdvisor to commercialise MedAdvisor’s platform across Asia.

ZPM has signed a software licence agreement for its medication management solutions on an exclusive basis for eight key markets - Singapore, Thailand, Indonesia, South Korea, Taiwan, Hong Kong, the Philippines and Malaysia.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 15. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

South-east Asia stocks end weaker as Trump threat jolts markets, Singapore divesBENGALURU — South-east Asian stocks closed lower on Monday (May 6) after US President Donald Trump threatened to hike tariffs on Chinese goods this week, rekindling trade tensions between Washington and Beijing, with Singapore leading the losses in the region.
출처: TODAYonline - 🏆 1. / 99 더 많은 것을 읽으십시오 »